Skip to main content

Table 7 Number of episodes and average cost (Euros) with the social perspective, according to age group and episode severity

From: Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

  

Most favourable scenario

Least favourable scenario

Age

Severity

Episodes (N)

Strategy 1 (€)

Strategy 2 (€)

Savings (€)

Savings (%)

Episodes (N)

Strategy 1 (€)

Strategy 2 (€)

Savings (€)

Savings (%)

18-64 years

Mild

3,775

210.7

193.9

16.8

7.98

315

68.7

63.5

5.2

7.59

Moderate

4,854

2,325.1

2,122.8

202.3

8.70

405

1,365.6

1,269.4

96.2

7.04

Severe

2,157

2,764.7

2,363.6

401.1

14.51

180

1,883.9

1,700.6

183.3

9.73

 

Total

10,787

1,673.0

1,495.9

177.2

10.59

899

1,015.3

933.6

81.8

8.05

≥ 65 years

Mild

997

209.8

193.9

15.9

7.58

83

68.5

63.5

5.1

7.40

Moderate

1,282

2,304.9

2,117.6

187.3

8.13

107

1,357.2

1,266.7

90.6

6.67

Severe

570

2,601.0

2,340.8

260.3

10.01

47

1,820.4

1,678.9

141.6

7.78

 

Total

2,849

1,630.9

1,489.0

141.9

8.70

237

998.8

928.0

70.8

7.09

TOTAL

 

13,636

1,664.2

1,494.4

169.8

10.20

1,136

1,011.9

932.4

79.5

7.85

  1. Strategy 1= Health professional-administration only; Strategy 2= Self-administration also available.
  2. Sensitivity Analysis.